Spectrum Pharmaceuticals, Inc.SPPINASDAQ

Revenue (LTM)

$10M

Net Income (LTM)

$-78M

+50.7% YoY

Free Cash Flow

$-97M

Revenue CAGR (5Y)

-44.9%

Marginsdeclining

FCF($0.1B)

Unprofitable

Metric	Dec 18	Dec 19	Dec 20	Dec 21	Dec 22
Revenue	109	23↓79.3%	0	0	10
Gross Profit	83	11↓87.2%	0	0	8
Operating Income	-131	-144↓9.8%	-170↓17.8%	-148↑13.0%	-73↑50.8%
Net Income	-120	-135↓12.8%	-171↓26.5%	-158↑7.5%	-78↑50.7%
EBITDA	-93	-155↓65.3%	-169↓9.6%	-147↑13.0%	-77↑47.7%
EPS Diluted	-1.16	-1.22↓5.2%	-1.38↓13.1%	-1.02↑26.1%	-0.43↑57.8%

Metric	Dec 18	Dec 19	Dec 20	Dec 21	Dec 22
Cash & Equivalents	157	64↓59.1%	46↓28.6%	89↑92.4%	40↓54.4%
Total Current Assets	251	244↓2.7%	187↓23.5%	104↓44.3%	101↓2.8%
Total Assets	391	263↓32.6%	197↓25.3%	112↓43.3%	103↓7.4%
Total Current Liabilities	86	62↓28.3%	53↓14.2%	53↑0.2%	43↓19.8%
Total Liabilities	108	73↓32.1%	63↓14.4%	64↑2.3%	75↑17.9%
Total Equity	283	190↓32.8%	134↓29.5%	48↓64.6%	28↓41.4%
Total Debt	0	4	2↓61.9%	1↓17.0%	29↑2195.4%
Net Debt	-157	-60↑61.7%	-44↑26.3%	-87↓96.2%	-11↑87.5%

Metric	Dec 18	Dec 19	Dec 20	Dec 21	Dec 22
Operating Cash Flow	-62	-135↓115.7%	-122↑9.7%	-119↑1.8%	-97↑18.8%
Capital Expenditure	-3	-9↓227.1%	-6↑38.6%	-0↑96.0%	-0↓23.5%
Free Cash Flow	-65	-144↓120.5%	-127↑11.5%	-120↑5.9%	-97↑18.7%
Stock-Based Comp	17	22↑24.9%	18↓18.4%	20↑11.3%	8↓57.2%
Net Change in Cash	-70	-93↓33.2%	-18↑80.2%	43↑331.0%	-48↓213.3%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance